Predictors of adherence to a new erythropoiesis-stimulating agent inpatient ordering policy: A cross-sectional study

BACKGROUND: Erythropoiesis-stimulating agents (ESAs) are recommended for treating anemia in patients with chronic kidney disease and end-stage renal disease. However, misappropriate and over-use of these agents can be costly and unnecessary in some settings. OBJECTIVE: The primary aim was to identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Alabdan, Numan, AlRuthia, Yazed, Yates, Mary E. D., Sales, Ibrahim, Finch, Christopher K., Hudson, Joanna Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705120/
https://www.ncbi.nlm.nih.gov/pubmed/29182650
http://dx.doi.org/10.1371/journal.pone.0188390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705120/
https://www.ncbi.nlm.nih.gov/pubmed/29182650
http://dx.doi.org/10.1371/journal.pone.0188390

Ejemplares similares